Octave Specialty (OSG) EBITDA (2010 - 2026)

Octave Specialty's EBITDA history runs 17 years deep, the most recent figure standing at -$14.1 million for Q1 2026.

• In Q1 2026, EBITDA fell 301.11% year-over-year to -$14.1 million; the TTM figure through Mar 2026 stood at -$67.1 million (up 88.47% YoY), while the FY2025 annual figure was -$64.8 million, up 88.92% from the prior year.
• EBITDA was -$14.1 million for Q1 2026 at Octave Specialty, up from -$33.3 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $235.9 million in Q4 2022 to a low of -$653.8 million in Q4 2024.
• Historically, EBITDA has averaged -$19.7 million across 5 years, with a median of $3.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBITDA slumped 12400.0% in 2022, then soared 7436.26% in 2025.
• A 5-year view of EBITDA shows it stood at $235.9 million in 2022, then slumped by 63.23% to $86.7 million in 2023, then slumped by 853.69% to -$653.8 million in 2024, then soared by 94.91% to -$33.3 million in 2025, then surged by 57.6% to -$14.1 million in 2026.
• The last three EBITDA figures came in at -$14.1 million (Q1 2026), -$33.3 million (Q4 2025), and -$39.8 million (Q3 2025), per Business Quant data.